Marshall Wace’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.27M Sell
1,146,707
-116,395
-9% -$571K 0.01% 1186
2026
Q1
$4.32M Buy
1,263,102
+708,922
+128% +$2.39M ﹤0.01% 1372
2025
Q4
$1.57M Buy
554,180
+241,990
+78% +$1.25M ﹤0.01% 1693
2025
Q3
$2.17M Sell
312,190
-91,816
-23% -$647K ﹤0.01% 1569
2025
Q2
$2.39M Buy
404,006
+98,171
+32% +$565K ﹤0.01% 1475
2025
Q1
$1.95M Buy
305,835
+281,305
+1,147% +$2.71M ﹤0.01% 1474
2024
Q4
$291K Sell
24,530
-6,570
-21% -$112K ﹤0.01% 2242
2024
Q3
$861K Buy
31,100
+5,200
+20% +$130K ﹤0.01% 1707
2024
Q2
$618K Buy
+25,900
New +$608K ﹤0.01% 1888
2023
Q4
Sell
-193,020
Closed -$1.66M 2163
2023
Q3
$1.66M Sell
193,020
-39,621
-17% -$281K ﹤0.01% 1311
2023
Q2
$1.84M Sell
232,641
-685,964
-75% -$4.77M ﹤0.01% 1443
2023
Q1
$6.84M Buy
+918,605
New +$9.13M 0.01% 850
2022
Q1
Sell
-2,846
Closed -$141K 3327
2021
Q4
$141K Buy
+2,846
New +$150K ﹤0.01% 3281

Other funds holding ASPN

Marshall Wace's ASPN Position: Q2 2026 in Review

Marshall Wace reduced its Aspen Aerogels (ASPN) stake by 9.2% in Q2 2026, selling an estimated $571K and leaving 1,146,707 shares worth $7.27M. The position accounts for 0.01% of the portfolio, ranked #1186.

Marshall Wace first reported a position in ASPN in Q4 2021 and has held it in 13 quarters since. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Marshall Wace held 1,146,707 shares of Aspen Aerogels worth $7.27M as of Q2 2026.
  • Marshall Wace sold 116,395 Aspen Aerogels shares in Q2 2026, an estimated $571K.
  • Aspen Aerogels made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1186 holding.
  • Marshall Wace first reported a position in Aspen Aerogels in Q4 2021 and has held it in 13 quarters since.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.